Stellar Biotechnologies Inc (SBOT.OQ)
SBOT.OQ on NASDAQ Stock Exchange Capital Market
Change (% chg)
Stellar Biotechnologies, Inc. is a biotechnology company. The Company is engaged in the aquaculture, research and development, manufacture and commercialization of Keyhole Limpet Hemocyanin (KLH). KLH is an immune-stimulating protein. KLH can be used as an active pharmaceutical ingredient (API) and combined with a disease-target... (more)
* STELLAR BIOTECHNOLOGIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS
* STELLAR BIOTECHNOLOGIES APPOINTS PHARMA LICENSING EXPERT TO BOARD OF DIRECTORS Source text for Eikon: Further company coverage:
Earnings vs. Estimates
No consensus analysis data available.